Retina structure

Palczewski, K., Polans, A. S., Baehr,W. and Ames, I. B. Ca2+-binding proteins in the retina structure, function, and the etiology of human visual diseases. BioEssays 22 337-350, 2000. 

Young, R. W. The organization of vertebrate photoreceptor cells. In The Retina Structure, function and clinical characteristics (eds. Straatsma, B., Allen, R., Hall, M. and Crescitelli, F., pp. 177-209. University of California Press, Los Angeles, 1969. 

The vibronic coupling model has been applied to a number of molecular systems, and used to evaluate the behavior of wavepackets over coupled surfaces [191]. Recent examples are the radical cation of allene [192,193], and benzene [194] (for further examples see references cited therein). It has also been used to explain the lack of structure in the S2 band of the pyrazine absoiption spectrum [109,173,174,195], and recently to study the photoisomerization of retina] [196],... 

The retina comprises two principal components, the non-neural retinal pigment epithelium and the neural retina. The retinal pigment epithelium is an essential component of the visual system both structurally and functionally. It is important for the turnover and phagocytosis of photoreceptor outer segments, the metabolism of retinoids, the exchange of nutrients between the photoreceptors, and the choroidal blood vessels and the maintenance of an efficient outer blood-retinal barrier. 

The observation that lutein and zeaxanthin occur in the highest concentration in the macula soon raised expectations that the macular xanthophylls may be essential in maintaining structure and function of the retina by contributing not only to risk reduction of macular diseases but also to improving visual performance of the healthy eye, which was the original hypothesis to explain the presence of the macular yellow pigment as mentioned previously. 

RPE plays numerous functions essential for proper structure and function of retinal photoreceptors. They include the maintenance of the blood-retina barrier, selective uptake and transport of nutrients from the blood to the retina and removal of waste products to the blood, enzymatic cleavage of P-carotene into vitamin A, storage of vitamin A and its metabolic transformations, phagocytosis and molecular renewal of POS, expression and secretion of growth factors and immunomodulatory cytokines (Aizman et al., 2007 Aleman et al., 2001 Crane et al., 2000a,b Elner et al., 2006 Holtkamp et al., 2001 Leuenberger et al., 2001 Lindqvist and Andersson, 2002 Maminishkis et al., 2006 Momma et al., 2003 Strauss, 2005). 

ApoC-II is expressed in liver and intestine, and both the neural retina and RPE (Li et al., 2006). In contrast to ApoC-I, it can function as an activator of lipoprotein lipase. Similar to ApoA-I, ApoA-II, and ApoE, in the absence of lipid to stabilize its structure, ApoC-II forms amyloid assemblies. 

Like living organisms themselves, cells come in a remarkable variety of flavors. Brown has described what might be a human cell with elaborate internal structure. However, there is no such a thing as a typical cell. Afunctional liver cell, a hepatocyte, is quite distinct from a nerve cell, a neuron, that, in turn, is not much like a cell of the retina of the eye. Skin cells, pancreatic cells, kidney cells, cells of the testis and ovary, red blood cells, bone cells, and on and on, are all structurally, functionally, and metabolically distinct. Indeed, there are several types of cells in the skin, pancreas, kidney, testis, ovary, and bone. Then there are the cells of bacteria and other microorganisms that have no nucleus or other membrane-limited organelles very different. Diversity abounds. 

The maintenance of the structure and function of photoreceptors in the eye depends on taurine. As an antioxidant, it may protect the cell membranes in the retina. 

Topical application is the most common route of administration for ophthalmic drugs. Advantages include convenience, simplicity, noninvasive nature, and the ability of the patient to self-administer. Because of blood and aqueous losses of drug, topical medications typically do not penetrate in useful concentrations to posterior ocular structures and therefore are of no therapeutic benefit for diseases of the retina, optic nerve, and other posterior segment structures. 

---